614 related articles for article (PubMed ID: 17393451)
1. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
2. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
3. Germline deletion of β2 microglobulin or CD1d reduces anti-phospholipid antibody, but increases autoantibodies against non-phospholipid antigens in the NZB/W F1 model of lupus.
Singh RR; Yang JQ; Kim PJ; Halder RC
Arthritis Res Ther; 2013 Mar; 15(2):R47. PubMed ID: 23531237
[TBL] [Abstract][Full Text] [Related]
4. Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.
Jacinto J; Kim PJ; Singh RR
Lupus; 2012 Apr; 21(5):485-90. PubMed ID: 22065098
[TBL] [Abstract][Full Text] [Related]
5. Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.
Yang JQ; Kim PJ; Singh RR
J Clin Immunol; 2012 Feb; 32(1):106-13. PubMed ID: 22002593
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis.
Yang JQ; Singh AK; Wilson MT; Satoh M; Stanic AK; Park JJ; Hong S; Gadola SD; Mizutani A; Kakumanu SR; Reeves WH; Cerundolo V; Joyce S; Van Kaer L; Singh RR
J Immunol; 2003 Aug; 171(4):2142-53. PubMed ID: 12902521
[TBL] [Abstract][Full Text] [Related]
7. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
Godó M; Sessler T; Hamar P
Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
[TBL] [Abstract][Full Text] [Related]
8. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
9. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.
Zeng D; Liu Y; Sidobre S; Kronenberg M; Strober S
J Clin Invest; 2003 Oct; 112(8):1211-22. PubMed ID: 14561706
[TBL] [Abstract][Full Text] [Related]
10. Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Clin Exp Immunol; 2000 Feb; 119(2):333-9. PubMed ID: 10632672
[TBL] [Abstract][Full Text] [Related]
11. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
12. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
[TBL] [Abstract][Full Text] [Related]
13. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice.
Yang JQ; Chun T; Liu H; Hong S; Bui H; Van Kaer L; Wang CR; Singh RR
Eur J Immunol; 2004 Jun; 34(6):1723-32. PubMed ID: 15162443
[TBL] [Abstract][Full Text] [Related]
14. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
15. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
16. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.
Yang JQ; Saxena V; Xu H; Van Kaer L; Wang CR; Singh RR
J Immunol; 2003 Oct; 171(8):4439-46. PubMed ID: 14530371
[TBL] [Abstract][Full Text] [Related]
17. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
Sprengers D; Sillé FC; Derkow K; Besra GS; Janssen HL; Schott E; Boes M
Gastroenterology; 2008 Jun; 134(7):2132-43. PubMed ID: 18549881
[TBL] [Abstract][Full Text] [Related]
18. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
19. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
20. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]